[Seroprevalence of herpes simplex virus type 2 (HSV-2) infection in two clinics for sexually transmitted diseases in Santiago, Chile].

BACKGROUND Genital herpes, a sexually transmitted disease caused by herpes simplex virus type 2 (HSV-2), is found in 3.8% of all sexually transmitted diseases (STD) in Chile. AIM To determine the seroprevalence of herpes simplex virus type 2 (HSV-2) and to identify an association between HSV-2 and HIV-1, other STD, and to study its demographic characteristics. MATERIAL AND METHODS A cross-sectional study at two STD public clinics in Santiago was conducted among 200 consecutive patients. Samples were tested for HSV-2, HIV-1, syphilis and hepatitis B virus surface antigen. RESULTS The seroprevalence for HSV-2 was 43%. Four patients had a history of genital herpes. There was a strong association between HSV-2 infection and HIV-1 positivity (OR=8.7, 95% CI 3.4-22.4, p <0.001) and the condition of being a sexual worker (OR=4.5, 95% CI 1.7-11.9, p <0.01). CONCLUSIONS The high association with HIV-1 and sexual workers, emphasizes the need of having HSV-2 specific diagnostic tests, counseling on sign and symptom recognition and taking preventive measures.

[1]  D. Dwyer,et al.  HSV type specific serology in sexual health clinics: use, benefits, and who gets tested , 2004, Sexually Transmitted Infections.

[2]  B. Stray-Pedersen,et al.  Seroprevalence and Correlates of Herpes Simplex Virus Type 2 Among Urban Tanzanian Women , 2003, Sexually transmitted diseases.

[3]  J. Steiner,et al.  Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. , 2002, The Journal of infectious diseases.

[4]  M. Andreoni,et al.  Prevalence and Determinants of Herpes Simplex Virus Type 2 Infection in a Cohort of HIV-Positive Individuals in Italy , 2002, Sexually transmitted diseases.

[5]  L. Corey Challenges in genital herpes simplex virus management. , 2002, The Journal of infectious diseases.

[6]  Anna Wald,et al.  Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Jennifer S. Smith,et al.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. , 2002, The Journal of infectious diseases.

[8]  W. Hogrefe,et al.  Detection of Herpes Simplex Virus Type 2-Specific Immunoglobulin G Antibodies in African Sera by Using Recombinant gG2, Western Blotting, and gG2 Inhibition , 2002, Journal of Clinical Microbiology.

[9]  M. Lipsitch,et al.  Projection of the Future Dimensions and Costs of the Genital Herpes Simplex Type 2 Epidemic in the United States , 2002, Sexually transmitted diseases.

[10]  A. Osterhaus,et al.  Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic. , 2001, International journal of epidemiology.

[11]  R. Dal-Ré,et al.  Herpes Simplex Virus Type 2 Seroepidemiology in Spain: Prevalence and Seroconversion Rate Among Sexually Transmitted Disease Clinic Attendees , 2001, Sexually transmitted diseases.

[12]  J. Tanaka,et al.  Hepatitis B epidemiology in Latin America. , 2000, Vaccine.

[13]  L. Corey The current trend in genital herpes. Progress in prevention. , 1994, Sexually transmitted diseases.

[14]  M. L. Soberón,et al.  Enfermedades de transmisión sexual , 1992 .